VOR (STOCKS)
Vor Biopharma Inc. Common Stock
$15.970000
+0.500000 (+3.23%)
Prev close: $15.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jean-Paul Kress
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $781.07M
- Employees
- 168
- P/E (TTM)
- -0.05
- P/B (TTM)
- -3.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$25.84 | $-1.69 | +27.5341 | +1,625.29% |
|
Sep 2025 (Q3)
|
$-3.33 | $-3.28 | -0.0455 | -1.39% |
|
Jun 2025 (Q2)
|
$-43.80 | $-8.86 | -34.9443 | -394.60% |
|
Mar 2025 (Q1)
|
$-5.20 | $-4.62 | -0.5829 | -12.62% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$324.34M |
| Operating Expenses | $371.64M |
| Research and Development | $321.53M |
| Other Operating Expenses | $50.11M |
| Operating Income/Loss | -$371.64M |
| Income/Loss From Continuing Operations After Tax | -$695.98M |
| Income/Loss From Continuing Operations Before Tax | -$695.98M |
| Net Income/Loss | -$695.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$695.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$695.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$70.50 |
| Diluted Earnings Per Share | -$70.50 |
| Basic Average Shares | 9,871,866 |
| Diluted Average Shares | 9,871,866 |
| Assets | $464.13M |
| Current Assets | $458.11M |
| Cash | $455.20M |
| Prepaid Expenses | $1.15M |
| Other Current Assets | $1.75M |
| Noncurrent Assets | $6.02M |
| Fixed Assets | $533.00K |
| Other Non-current Assets | $5.49M |
| Liabilities | $628.44M |
| Current Liabilities | $25.17M |
| Accounts Payable | $5.13M |
| Wages | $3.07M |
| Other Current Liabilities | $16.98M |
| Noncurrent Liabilities | $603.27M |
| Equity | -$164.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$164.31M |
| Liabilities And Equity | $464.13M |
| Net Cash Flow From Operating Activities | -$142.71M |
| Net Cash Flow From Operating Activities, Continuing | -$142.71M |
| Net Cash Flow From Investing Activities | -$48.80M |
| Net Cash Flow From Investing Activities, Continuing | -$48.80M |
| Net Cash Flow From Financing Activities | $503.81M |
| Net Cash Flow From Financing Activities, Continuing | $503.81M |
| Net Cash Flow | $312.29M |
| Net Cash Flow, Continuing | $312.29M |
| Comprehensive Income/Loss | -$695.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$695.96M |
| Other Comprehensive Income/Loss | $19.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $19.00K |